Abiopharma

🔍 Keeney Scott H (Director)

Company: NLIGHT, INC. (LASR)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 99,706 shares of Common Stock at $1.45 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,284,745.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 82,044 shares of Common Stock at $1.45 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,366,789.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 64,729 shares of Common Stock at $46.29 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,302,060.00 | transaction_form_type: 4 | Footnotes: F3, F2, F1
• Sold 112,470 shares of Common Stock at $47.15 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,189,590.00 | transaction_form_type: 4 | Footnotes: F4, F2, F1
• Sold 2,459 shares of Common Stock at $47.92 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,187,131.00 | transaction_form_type: 4 | Footnotes: F5, F2, F1
• Sold 2,092 shares of Common Stock at $48.97 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,185,039.00 | transaction_form_type: 4 | Footnotes: F6, F2, F1
• Acquired 181,750 shares of Common Stock at $1.45 per share (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,366,789.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 155,008 shares of Common Stock at $44.03 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,211,781.00 | transaction_form_type: 4 | Footnotes: F7, F2, F1
• Sold 25,039 shares of Common Stock at $44.79 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,186,742.00 | transaction_form_type: 4 | Footnotes: F8, F2, F1
• Sold 1,703 shares of Common Stock at $45.92 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,185,039.00 | transaction_form_type: 4 | Footnotes: F9, F2, F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: By Keeney Family Revocable Trust | shares_owned_after: 501.00 | Footnotes: F10
• Sold 99,706 shares of Stock Option (Right to Buy) at $1.45 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2027-06-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F11
• Sold 82,044 shares of Stock Option (Right to Buy) at $1.45 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2027-06-02 | equity_swap_involved: 0 | shares_owned_after: 181,750.00 | transaction_form_type: 4 | Footnotes: F12
• Sold 181,750 shares of Stock Option (Right to Buy) at $1.45 per share (Derivative)
  Date: 2026-08-24 | Code: M | Expires: 2027-06-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F12

Footnotes:

• F1: Includes common stock owned and unvested restricted stock units.
• F2: This reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026.
• F3: The reported transaction involves sale transactions from $45.72 to $46.71 per share. The weighted average price per share was $46.29. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
• F4: The reported transaction involves sale transactions from $46.72 to $47.71 per share. The weighted average price per share was $47.15. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
• F5: The reported transaction involves sale transactions from $47.72 to $48.71 per share. The weighted average price per share was $47.92. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
• F6: The reported transaction involves sale transactions from $48.72 to $49.16 per share. The weighted average price per share was $48.97. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
• F7: The reported transaction involves sale transactions from $43.54 to $44.54 per share. The weighted average price per share was $44.03. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
• F8: The reported transaction involves sale transactions from $44.54 to $45.51 per share. The weighted average price per share was $44.79. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
• F9: The reported transaction involves sale transactions from $45.54 to $46.48 per share. The weighted average price per share was $45.92. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
• F10: Keeney Family Revocable Trust is a revocable living trust for which the reporting person and his spouse are trustees.
• F11: This grant became fully vested and exercisable on June 1, 2022.
• F12: This grant became fully vested and exercisable on December 1, 2021.